Results 31 to 40 of about 1,202 (173)

Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice

open access: yesChinese Medical Journal, 2019
. Background:. Adiponectin is the most abundant adipokines that plays critical roles in the maintenance of energy homeostasis as well as inflammation regulation.
Wen-Ze Xiao, Li Zhang, Li-Min Chen
doaj   +3 more sources

Strengthening monocarboxylate transporters by adiponectin receptor agonist ameliorates diabetic peripheral neuropathy [PDF]

open access: yesCell Communication and Signaling
Background Disruption of energy support to peripheral nerves leads to dysfunction and degeneration of both neuronal axons and Schwann cells (SCs).
Tae Woo Kim   +10 more
doaj   +2 more sources

Therapeutic potential of Adiponectin and AdipoRon in Duchenne Muscular Dystrophy

open access: yes, 2018
Adiponectin (ApN) is a hormone known to possess powerful anti-inflammatory effects on various tissues, including the skeletal muscle. Duchenne Muscular Dystrophy (DMD) is the most devastating type of muscular dystrophy.
Abou Samra, Michel
core   +2 more sources

Potential therapeutic action of AdipoRon in Duchenne Muscular Dystrophy

open access: yes, 2019
Adiponectin (ApN) is a hormone tightly linked to the metabolic syndrome where it exerts anti-diabetic actions. It is also known to possess powerful anti-inflammatory effects on skeletal muscle exposed to acute and chronic inflammation, through AdipoR1 ...
Abou Samra, Michel, Myology 2019
core   +2 more sources

Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling [PDF]

open access: yesCells
As part of chemotherapy regimens, Paclitaxel improves the overall survival of many non-small cell lung cancer (NSCLC) patients. However, the development of drug resistance and adverse events limits its clinical usage, reinforcing the need for further ...
Sanober Kafeel   +5 more
doaj   +2 more sources

A Novel Small-Molecule Dual Adiponectin Receptor 1/2 Agonist Induces Myogenesis and Ameliorates Skeletal Muscle Atrophy. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
ABSTRACT Background Skeletal muscle atrophy is a hallmark of ageing and chronic diseases, yet effective pharmacotherapies remain unavailable. Adiponectin signalling through AdipoR1 and AdipoR2 regulates skeletal muscle metabolism, regeneration and oxidative capacity, but the therapeutic use of adiponectin is limited by its large size and complex ...
Das S   +14 more
europepmc   +2 more sources

Selective Small-Molecule AdipoR1 Agonist 3-Hydroxy Pterocarpan Salt (CDRI-1709S) Ameliorates Skeletal Muscle Atrophy. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
ABSTRACT Background Skeletal muscle atrophy is a frequent comorbidity of metabolic disorders and chronic diseases, and despite its high prevalence, no pharmacological therapy is available, representing a major unmet clinical need. Adiponectin and its receptors are key regulators of skeletal muscle metabolism, mitochondrial function and myogenesis, yet ...
Moin MR   +12 more
europepmc   +2 more sources

Elevated Kallistatin Induces Myosteatosis and Exercise Intolerance by Antagonizing AdipoR1-Mediated AMPK Signalling. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
ABSTRACT Background Pathological intramuscular lipid deposition (myosteatosis) and exercise intolerance are hallmarks of metabolic disorders, including diabetes and metabolic dysfunction‐associated steatotic liver disease (MASLD), yet their underlying mechanisms remain unclear.
Hong F   +13 more
europepmc   +2 more sources

AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
The high mortality rate together with an ever-growing number of annual cases have defined neoplastic disorders as “the real 21st-century disease”. Its dubious distinction also results from conventional therapy failure, which has made cancer an orphan disease. Therefore, innovative and alternative therapeutic strategies are mandatory.
Ersilia Nigro   +5 more
openaire   +3 more sources

AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy

open access: yes, 2019
Adiponectin (ApN) is a hormone known to possess powerful anti inflammatory and pro myogenic effects on skeletal muscle. Duchenne muscular dystrophy (DMD) is a devastating disease characterized by dystrophin deficiency with subsequent chronic inflammation,
Abou Samra, Michel   +1 more
core   +2 more sources

Home - About - Disclaimer - Privacy